Insider · CIK 0002030840
Michael Heltzen
Files at EXOZ (EXOZYMES INC.). First filing Nov 19, 2024, latest Sep 2, 2026.
Michael Heltzen files SEC Form 4 as CEO at EXOZ (EXOZYMES INC.). Since Nov 19, 2024, Michael Heltzen has reported 4 open-market buys worth $59k and 0 open-market sells worth $0, the latest filed on Sep 2, 2026.
A track record needs three past buys with six months of prices behind them; Michael Heltzen has 0, so none is measured yet.
The newest scored trade: bought $6,405 of EXOZ on Aug 25, 2026, filed Sep 2, 2026, scored 28 (weak). In the last 12 months: 1 buy worth $6,405 and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
EXOZ: EXOZYMES INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | EXOZbuy EXOZYMES INC. | $6,405 855 shares | +6% | - | |
| 36Weak | EXOZbuy EXOZYMES INC. | $11k 1,040 shares | +11% | +18% from low-50% from high | |
| 40Moderate | EXOZbuy EXOZYMES INC. | $20k 1,888 shares | +95% | - | |
| 33Weak | EXOZbuy EXOZYMES INC. | $22k 1,984 shares | - | - |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | EXOZ EXOZYMES INC. | POpen-market purchase Common Stock | +4 | $7.58 | $30 | 14,708 | 41 d ago |
| Aug 26, 2026 | EXOZ EXOZYMES INC. | POpen-market purchase Common Stock | +251 | $7.35 | $1,845 | 14,704 | 41 d ago |
| Aug 26, 2026 | EXOZ EXOZYMES INC. | POpen-market purchase Common Stock | +250 | $7.60 | $1,900 | 14,453 | 41 d ago |
| Aug 25, 2026 | EXOZ EXOZYMES INC. | POpen-market purchase Common Stock | +250 | $7.52 | $1,880 | 14,203 | 41 d ago |
| Aug 25, 2026 | EXOZ EXOZYMES INC. | POpen-market purchase Common Stock | +100 | $7.50 | $750 | 13,953 | 41 d ago |
| Aug 19, 2026 | EXOZ EXOZYMES INC. | AGrant or award Common Stock | +8,841 | $6.40 | $57k | 13,853 | 41 d ago |
| Jul 2, 2025 | EXOZ EXOZYMES INC. | POpen-market purchase Common Stock | +1,040 | $10.22 | $11k | 10,629 | Jul 2, 2025 |
| Jun 17, 2025 | EXOZ EXOZYMES INC. | AGrant or award Stock Options for Common Stockderivative | +235,817 | $0.00 | $0 | 235,817 | Jun 20, 2025 |
| Jan 16, 2025 | EXOZ EXOZYMES INC. | POpen-market purchase Common Stock | +121 | $10.72 | $1,297 | 2,105 | Jan 21, 2025 |
| Jan 17, 2025 | EXOZ EXOZYMES INC. | POpen-market purchase Common Stock | +1,767 | $10.78 | $19k | 3,872 | Jan 21, 2025 |
| Nov 15, 2024 | EXOZ EXOZYMES INC. | POpen-market purchase Common Stock | +1,984 | $11.10 | $22k | 1,984 | Nov 19, 2024 |
Questions about Michael Heltzen
Answered from the filings on this page, as of the latest one.
Is Michael Heltzen buying or selling?
In the last 12 months Michael Heltzen reported 1 open-market buy worth $6,405 and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $6,405 of EXOZ on Aug 25, 2026. Grants, option exercises and tax withholding are not counted.
How did Michael Heltzen's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Heltzen has 0.
Where does Michael Heltzen file Form 4?
Michael Heltzen has filed Form 4 at EXOZ (EXOZYMES INC.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.